Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Will the Resorbable Vascular Scaffolds Market’s Growth Rate Evolve Over the Forecast Period to 2034?

In the past few years, there has been a swift expansion in the resorbable vascular scaffolds market. The market is expected to surge from $0.46 billion in 2024 to $0.52 billion in 2025, signifying a compound annual growth rate (CAGR) of 12.9%. Factors such as a rise in cardiovascular disease cases, enhanced health consciousness among individuals, increasing incidence of coronary artery disease (CAD), growing preference for minimally invasive procedures and a surge in diabetes instances have been the driving forces behind the remarkable growth witnessed during the historical period.

The market size of resorbable vascular scaffolds is anticipated to experience swift expansion in the coming years. By 2029, the market is predicted to reach a value of $0.83 billion, with a compound annual growth rate (CAGR) of 12.6%. The surge during the forecast period can be credited to the increasing risk of coronary artery disease (CAD) and peripheral artery disease (PAD) among the elderly, the escalation in funding for research and development (R&D) related to surgical methods, the rising aging population, higher healthcare expenditure, and a surge in the prevalence of coronary artery disease. The forecast period will see major trends such as a preference for drug-eluting devices in angioplasty, the advent of technology and innovation in products, breakthroughs in stent technology, and advancements in diagnostic technologies.

What Major Innovations Are Driving the Accelerated Growth of the Resorbable Vascular Scaffolds Market?

The rise in cardiovascular disease incidences is projected to stimulate the growth of the resorbable vascular scaffolds market. Lifestyle factors, aging, heightened blood pressure, elevated cholesterol levels, diabetes, smoking, and genetic influences are among the drivers of cardiovascular diseases. Resorbable vascular scaffolds are transforming the way cardiovascular conditions are treated, by temporarily supporting the structure to improve blood flow, while slowly dissolving over time. This minimizes long-term complications related to permanent implants and encourages natural healing and functionality of the vessels. For example, as per the Minnesota Department of Health, a state agency located in the US, 4% of Minnesota’s adult population, nearing 180,000 individuals, underwent a heart attack in 2023. Also, heart disease accounted for nearly 17% of the total death count in the state, causing 8,972 deaths in 2022. Hence, the escalating occurrence of cardiovascular diseases is bolstering the expansion of the resorbable vascular scaffolds market.

Explore Comprehensive Insights Into The Global Resorbable Vascular Scaffolds Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21272&type=smp

Who Are the Influential Players Reshaping the Resorbable Vascular Scaffolds Market Landscape?

Major companies operating in the resorbable vascular scaffolds market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, Getinge Group, Biotronik, LivaNova plc, Lepu Medical Technology, Gore Medical, Biosensors International, Blue Medical, Reva Medical, Elixir Medical, S3V Vascular Technologies, Amaranth Medical Inc., Meril Life Sciences Pvt. Ltd., Arterius Limited, Zorion Medical, Kyoto Medical Planning Co. Ltd., ICON Interventional Systems.

What New and Evolving Trends Are Having a Lasting Impact on the Resorbable Vascular Scaffolds Market?

Leading industry players in the resorbable vascular scaffolds market are endeavoring to produce magnesium scaffolds in a bid to advance biocompatibility and enhance mechanical support. This variety of scaffolds, by virtue of being magnesium-based, foster organic healing of vessels while simultaneously diminishing inflammation and complications that are typically associated with conventional polymer-based equivalents. For example, in March 2024, Biotronik, a German medical device firm, was granted breakthrough device designation by the FDA for their Freesolve below-the-knee resorbable magnesium scaffold (BTK RMS). This pioneering device, specifically established for patients afflicted by chronic limb-threatening ischemia (CLTI), presents an innovative alternative for BTK procedures. It comes equipped with a BIOmag magnesium alloy and Orsiro drug-eluting stent (DES) coating technology, which heightens safety, deliverability, and support for vessels. The scaffold also presents temporary support against vessel recoil during its convalescence.

Secure Your Global Resorbable Vascular Scaffolds Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/resorbable-vascular-scaffolds-global-market-report

Which Key Segments Stand Out in Understanding the Composition of the Resorbable Vascular Scaffolds Market?

The resorbable vascular scaffolds market covered in this report is segmented –

1) By Product Design: Multilumen, Single Lumen

2) By Material Type: Poly-Glycolic Acid, Poly-L-Lactic Acid, Poly-L-Lactic-Co-Glycolic Acid

3) By Deployment Technique: Balloon-Expandable, Self-Expandable

4) By Application: Coronary Artery Disease, Peripheral Vascular Disease, Pulmonary Artery Disease

5) By End User: Ambulatory Surgical Centers, Hospitals, Specialty Clinics

Subsegments:

1) By Multilumen: Helical Design, Braided Design, Other Multilumen Designs

2) By Single Lumen: Straight Tube Design, Corrugated Tube Design, Other Single Lumen Designs

Which Geographic Locations Are Critical to the Growth of the Resorbable Vascular Scaffolds Market?

North America was the largest region in the resorbable vascular scaffolds market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the resorbable vascular scaffolds market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Characteristics That Define the Resorbable Vascular Scaffolds Market?

Resorbable vascular scaffolds are medical devices used to treat vascular diseases by providing temporary structural support to blood vessels. Resorbable vascular scaffolds gradually dissolve after fulfilling their purpose, reducing the risks associated with permanent implants. By promoting natural vessel healing and restoring normal blood flow, they offer a safer and more effective alternative to traditional stents.

Browse Through More Similar Reports By The Business Research Company:

Cell Regeneration Medicine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-regeneration-medicine-global-market-report

Generalized Anxiety Disorder Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/generalized-anxiety-disorder-global-market-report

Specialty Generics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/specialty-generics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: